COMMUNIQUÉS West-GlobeNewswire

CytomX Therapeutics Announces First Quarter 2019 Financial Results
09/05/2019
Company to Host a Conference Call Today, May 9, 2019, at 5:00 p.m. EDT / 2:00 p.m. PDT SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology- [...]
Spero Therapeutics Announces First Quarter 2019 Operating Results and Provides Pipeline Review
09/05/2019
SPR994 pivotal Phase 3 trial underway and screening patients; multiple clinical catalysts ahead in 2H19 CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical- [...]
Calithera Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights
09/05/2019
--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on May 9, 2019-- SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a [...]
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Academy of Neurology Annual Meeting
09/05/2019
~ Results Demonstrate Long-term Treatment with KEVEYIS is Efficacious and Provides Durable Reduction in Attack Frequency and Severity in Patients with PPP ~ DUBLIN, Ireland and TREVOSE, Pa., May 09, 2019 (GLOBE NEWSWIRE [...]
Cerecor Reports First Quarter 2019 Results
09/05/2019
- Positive interim results from the Phase l study of CERC-301 in nOH -Positive results from Phase I Safety Data for CERC-801 in Healthy Volunteers ROCKVILLE, Md., May 09, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: [...]
ICU Medical, Inc. Announces First Quarter 2019 Results
09/05/2019
SAN CLEMENTE, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Opiant Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
SANTA MONICA, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today reported [...]
HTG Molecular Diagnostics Reports First Quarter 2019 Results
09/05/2019
Call scheduled for today, May 9, at 4:30pm ET TUCSON, Ariz., May 09, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, [...]
Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
09/05/2019
NEWTOWN, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial [...]
Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
09/05/2019
Enrollment in Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke to begin in Q3 CHARLOTTESVILLE, Va., May 09, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge [...]
Assembly Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights
09/05/2019
SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
BeiGene Reports First Quarter 2019 Financial Results
09/05/2019
CAMBRIDGE, Mass. and BEIJING, China, May 09, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
MENLO PARK, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Marrone Bio Innovations, Inc. Reports First-Quarter 2019 Financial Results
09/05/2019
First-Quarter 2019 Revenues More Than Doubled to $8.7 Million, with Gross Margins of 57 Percent DAVIS, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in [...]
Yield10 Bioscience Announces First Quarter 2019 Financial Results
09/05/2019
WOBURN, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Caladrius Biosciences Reports 2019 First Quarter Financial Results and Provides Corporate Update
09/05/2019
All enrolling clinical programs advancing with top-line data expected in late 2019 and during 1H2020 for CLBS14-CMD and CLBS12, respectively CLBS14-NORDA phase 3 program targeted to begin enrollment in late 2019 Cash on [...]
MyoKardia Reports First Quarter 2019 Financial Results
09/05/2019
Announces Enrollment Completing in the Phase 2 MAVERICK-HCM Trial Company to Host Conference Call and Webcast Today at 4:30 p.m. ET (1:30 p.m. PT) SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- MyoKardia [...]
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
09/05/2019
Continuing to execute commercial build and launch readiness for Gvoke HypoPen™ and Gvoke PFS ™ Dosed first patient in a Phase 2 study evaluating ready-to-use (RTU) glucagon in EIH Advancing diazepam to Phase 2 based on [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
09/05/2019
Reports Net Revenues of $79.8 Million for the Three Months Ended March 31, 2019 RANCHO CUCAMONGA, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) [...]

Pages